Dopamine-deficient mice are hypersensitive to dopamine receptor agonists

Journal of Neuroscience

Volumn 20, Issue 12, 2000, Pages 4405-4413

  Kim, Douglas S ^a   Szczypka, Mark S ^a,b   Palmiter, Richard D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

c Fos; Caudate putamen; D1 receptor; D2 receptor; Dopamine; Dopamine transporter; Haloperidol; Knock out mice; L 3,4 dihydroxyphenylalanine (L DOPA); Nucleus accumbens; Quinpirole; SCH 23390; SKF 81297; Striatum; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; LEVODOPA; LIGAND; QUINPIROLE; TYROSINE 3 MONOOXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; GENE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034660063     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-12-04405.2000     Document Type: Article

References (61)

1. 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography. J Neurosci 7:213-222.
2. Birkmayer W, Hornykiewicz O (1961) Der L-Dihydroxyphenylalanin (L-dopa) - Effekt bei der Parkinson-Akinese. Wien Klin Wschr 73:787-788.
3. Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC (1997) Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 94:3363-3367.
4. Cangiano A (1985) Denervation supersensitivity as a model for the neural control of muscle. Neuroscience 14:963-971.
5. Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, Witta J, Magnuson MA, Nikodem VM (1998) Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurrl gene. Mol Cell Neurosci 11:36-46.
6. Cho MC, Rao M, Koch WJ, Thomas SA, Palmiter RD, Rockman HA (1999) Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine. Circulation 99:2702-2707.
7. Choulli K, Herman JP, Rivet JM, Simon H, Le Moal M (1987) Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat. Brain Res 407:376-380.
8. Cole DG, Kobierski LA, Konradi C, Hyman SE (1994) 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci USA 91:9631-9635.
9. Cotzias GC, Van Wocrt MH, Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. N Engl J Med 276:374-379.
10. s-protein coupling. Eur J Pharmacol 207:271-274.
11. Dewar KM, Soghomonian JJ, Bruno JP, Descarries L, Reader TA (1990) Elevation of dopamine D2 but not D1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res 536:287-296.
12. Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261-265.
13. Dravid A, Jaton AL, Enz A, Frei P (1984) Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra. Brain Res 311:361-365.
14. Duncan GE, Breese GR, Criswell HE, Johnson KB, Schambra UB, Mueller RA, Caron MG, Fremcau Jr RT (1993) D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development. J Neurochem 61:1255-1262.
15. 2+, cAMP-responsive element binding proteins, and mitogen-activated protein kinase signaling. J Neurosci 17:7252-7266.
16. Fischer E, Heller B (1967) Pharmacology of the mechanism of certain effects of reserpine in the rat. Nature 216:1221-1222.
17. Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271-1283.
18. Foster GA, Schultzherg M, Hokfelt T, Goldstein M, Hemmings Jr HC, Ouimet CC, Walaas SI, Greengard P (1988) Ontogeny of the dopamine and cyclic adenosine-3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) in the pre-and postnatal mouse central nervous system. Int J Dev Neurosci 6:367-386.
19. Goldstein JM, Barnett A, Malick JB (1975) The evaluation of antiparkinson drugs on reserpine-induced rigidity in rats. Eur J Pharmacol 33:183-188.
20. olf in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci 13:2237-2248.
21. Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18:925-964.
22. Hossain MA, Weiner N (1993) Dopaminergic functional supersensitivity: effects of chronic L-DOPA and carbidopa treatment in an animal model of Parkinson's disease. J Pharmacol Exp Ther 267:1105-1111.
23. Ito K, Haga T, Lameh J, Sadee W (1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-119.
24. Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK (1992) Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine. J Pharmacol Exp Ther 261:1282-1290.
25. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, Bunzow JR, Fang Y, Gerhardt GA, Grandy DK, Low MJ (1998) Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18:3470-3479.
26. Konradi C, Cole RL, Heckers S, Hyman SE (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 14:5623-5634.
27. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19:1-17.
28. LaHoste GJ, Yu J, Marshall JF (1993) Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 90:7451-7455.
29. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinson-ism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
30. Langston JW, Langston EB, Irwin I (1984) MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurol Scand [Suppl] 100:49-54.
31. Liu FC, Graybiel AM (1996) Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron 17:1133-1144.
32. Liu FC, Graybiel AM (1998) Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia. Proc Natl Acad Sci USA 95:4708-4713.
33. Luthman J, Lindqvist E, Young D, Cowburn R (1990) Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity. Exp Brain Res 83:85-95.
34. Moore KE, Rech RH (1967) Reversal of α-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine. J Pharm Pharmacol 19:405-407.
35. Morelli M (1997) Dopamine/glutamatc interaction as studied by combining turning behaviour and c-Fos expression. Neurosci Biobehav Rev 21:505-509.
36. Morelli M, Di Chiara G (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182:611-612.
37. Morelli M, De Montis G, Di Chiara G (1990) Changes in the D1 receptor-adenylate cyclase complex after priming. Eur J Pharmacol 180:365-367.
38. Morelli M, Fenu S, Pinna A, Di Chiara G (1992) Opposite effects of NMDA receptor blockade on dopaminergic D1-and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260:402-408.
39. Moy SS, Criswell HE, Breese GR (1997) Differential effects of bilateral dopamine depletion in neonatal and adult rats. Neurosci Biobehav Rev 21:425-435.
40. Paul ML, Graybiel AM, David JC, Robertson HA (1992) D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 12:3729-3742.
41. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
42. 2+ channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci 19:6348-6359.
43. Rech RH, Borys HK, Moore KE (1966) Alterations in behavior and brain catecholamine levels in rats treated with α-methyltyrosine. J Pharmacol Exp Ther 153:412-419.
44. Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI, Curran T (1995) Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron 14:241-252.
45. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM (1998) Nurrl is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 95:4013-4018.
46. 125I]RTI-121. Synapse 21:364-372.
47. Szczypka MS, Rainey MA, Kim DS, Alaynick WA, Marck BT, Matsumoto AM, Palmiter RD (1999) Feeding behavior in dopamine-deficient mice. Proc Natl Acad Sci USA 96:12138-12143.
48. Thomas SA, Marck BT, Palmiter RD, Matsumoto AM (1998) Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70:2468-2476.
49. Tiheri M, Nash SR, Bertrand L, Lefkowitz RJ, Caron MG (1996) Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J Biol Chem 271:3771-3778.
50. Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107-110.
51. Ungerstedt U (1971a) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand [Suppl] 367:69-93.
52. Ungerstedt U (1971b) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand [Suppl] 367:49-68.
53. Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485-493.
54. Ungerstedt U, Ljungberg T, Steg G (1974) Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons. Adv Neurol 5:421-426.
55. Walters ET, Alizadeh H, Castro GA (1991) Similar neuronal alterations induced by axonal injury and learning in Aplysia. Science 253:797-799.
56. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285-1296.
57. White FJ, Kalivas PW (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153.
58. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S (1994) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742.
59. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T (1997) Dopamine neuron agenesis in Nurrl-deficient mice. Science 276:248-250.
60. Zhou QY, Palmiter RD (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209.
61. Zigmond MJ, Stricker EM (1973) Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science 182:717-720.